COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Drug Studies-in vitro
Last updated: 2025 Mar 18
Total hit(s): 1262
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
40590376
SARS-CoV-2 RNA-binding protein suppresses extracellular miRNA release.
RNA Biol
2025 Dec
1
2
40077853
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.
RNA Biol
2025 Dec
1
3
40578708
Nonthermal plasma jet mitigates viral replication and inflammation in human coronavirus 229E-infected lung cells by targeting the NF-kappaB and MAPK pathways.
Microb Pathog
2025 Sep
2.64
1
4
40619617
Engineered Dual-Function Antibody-Like Proteins to Combat SARS-CoV-2-Induced Immune Dysregulation and Inflammation.
Adv Sci (Weinh)
2025 Jul 6
1
5
40252899
Discovery of cinnamoyl-flavonoid hybrid derivatives as inhibitors of SARS-CoV-2 M(pro) and anti-inflammatory agents: Experimental and in silico insights into their efficacy against lipopolysaccharide-induced lung injury.
Eur J Pharmacol
2025 Jul 5
3.24
1
6
40650237
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.
Int J Mol Sci
2025 Jul 4
4.21
1
7
40676448
Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.
Drug Deliv Transl Res
2025 Jul 17
1
8
40670289
Oral Administration of Water-Soluble Curcumin Complex Prevents ARDS With the Potential for COVID-19 Treatment.
Phytother Res
2025 Jul 16
7.5
1
9
40652684
SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population.
Vaccine
2025 Jul 12
3.31
1
10
40594111
SARS-CoV-2 infection promotes lung thrombosis by inducing integrinbeta3 expression in vascular endothelial cells.
Sci Rep
2025 Jul 1
4.12
1
11
40596171
Antiviral and anti-inflammatory efficacy of nanoencapsulated brazilian green propolis against SARS-CoV-2.
Sci Rep
2025 Jul 1
4.12
1
12
40593736
Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids.
Nat Commun
2025 Jul 1
11.8
1
13
40488359
Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024.
Microbiol Spectr
2025 Jun 9
4.6
1
14
40459233
Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance.
J Infect Dis
2025 Jun 3
4.73
1
15
40571942
The ACE2 decoy receptor can overcome immune escape by rapid mutating SARS-CoV-2 variants and reduce cytokine induction and clot formation.
J Biomed Sci
2025 Jun 26
15.5
1
16
40666984
PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production.
bioRxiv
2025 Jun 24
- n/a -
1
17
40549074
An in-vitro and in-silico approaches in exploring the molecular contact of COVID-19 antiviral drug molnupiravir with human serum albumin: effect of binding on protein structure.
J Comput Aided Mol Des
2025 Jun 23
1
18
40543162
Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods.
Biomed Pharmacother
2025 Jun 20
3.83
1
19
40585204
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.
Res Sq
2025 Jun 20
- n/a -
1
20
40547706
In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket.
ACS Omega
2025 Jun 17
2.55
1
21
40503916
GSDMD and GSDME exhibit distinct roles in enteric coronavirus PDCoV-induced pyroptosis and inflammatory responses.
J Virol
2025 Jun 12
4.16
1
22
40498855
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
Sci Transl Med
2025 Jun 11
11.64
1
23
40254136
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
J Control Release
2025 Jun 10
15.5
1
24
40160515
In silico studies to understand the interactions of flavonoid inhibitor with nsp12-RNA dependent RNA polymerase of SARS-CoV-2 and its homologs.
Biochem Biophys Rep
2025 Jun
1.65
1
25
40442985
Pathological Glucose Levels Enhance Entry Factor Expression and Hepatic SARS-CoV-2 Infection.
J Cell Mol Med
2025 Jun
4.59
1